Cell death in acromegalic cardiomyopathy

Circulation

Volumn 99, Issue 11, 1999, Pages 1426-1434

  Frustaci, Andrea ^a   Chimenti, Cristina ^a   Setoguchi, Manabu ^b   Guerra, Sabrina ^b   Corsello, Salvatore ^a   Crea, Filippo ^a   Leri, Annarosa ^b   Kajstura, Jan ^b   Anversa, Piero ^b   Maseri, Attilio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Cardiomyopathy; Cells; Heart failure growth substances

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADULT; AGED; ANGIOCARDIOGRAPHY; APOPTOSIS; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HOLTER MONITORING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS ADENOMA; MALE; PRIORITY JOURNAL; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0033596928     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.11.1426     Document Type: Article

References (33)

1. McGuffin WL, Sherman BM, Roth J, Gorden P, Kahn CR, Roberts WC, Frommer PL. Acromegaly and cardiovascular disorders: a prospective study. Ann Intern Med. 1974;81:11-18.
2. Fazio S, Cittadini A, Cuocolo A, Merola B, Sabatini D, Colao A, Biondi B, Lombardi G, Saccà L. Impaired cardiac performance is a distinct feature of uncomplicated acromegaly. J Clin Endocrinol Metab. 1994; 79:441-446.
3. Lie JT, Grossman SJ. Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. Am Heart J. 1980;100:41-52.
4. Melmed S. Acromegaly. N Engl J Med. 1990;322:966-977.
5. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw B-A. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 1996;335:1182-1189.
6. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P. Apoptosis in the failing human heart. N Engl J Med. 1997;336:1131-1141.
7. Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, Traganos F. Cytometry in cell necrobiology: analysis of apoptosis, accidental cell death and necrosis. Cytometry. 1997;27:1-20.
8. Anversa P, Olivetti G, Leri A, Liu Y, Kajstura J. Myocyte cell death and ventricular remodeling. Curr Opin Nephrol Hypertens. 1997;6:169-176.
9. Li Z, Bing OHL, Long X, Robinson KG, Lakatta EG. Increased cardiomyocyte apoptosis during the transition from hypertrophy to heart failure in the spontaneously hypertensive rats. Am J Physiol. 1997;272: H2313-H2319.
10. Cheng W, Li B, Kajstura J, Li P, Wolin MS, Sonnenblick EH, Hintze TH, Olivetti G, Anversa P. Stretch-induced programmed myocyte cell death. J Clin Invest. 1995;96:2247-2259.
11. Leri A, Claudio PP, Li Q, Wang X, Reiss K, Wang S, Malhotra A, Kajstura J, Anversa P. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J Clin Invest. 1998;101:1326-1342.
12. Cheng W, Kajstura J, Nitahara JA, Li B, Reiss K, Liu Y, Clark WA, Krajewski S, Reed JC, Olivetti G, Anversa P. Programmed cell death contributes to ventricular remodeling after myocardial infarction in rats. Exp Cell Res. 1996;226:316-327.
13. Anversa P, Olivetti G, Meggs LG, Sonnenblick EH, Capasso JM. Cardiac anatomy and ventricular loading after myocardial infarction. Circulation. 1993;87(suppl II):VII-22-VII-27.
14. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation. 1977;55:613-618.
15. Didenko VV, Hornsby PJ. Presence of double-stranded breaks with single-base 3′ overhangs in cells undergoing apoptosis but not necrosis. J Cell Biol. 1996;135:1369-1376.
16. Snedecor GW, Cochran WG. Statistical Methods. 7th ed. Ames, Iowa: Iowa State University Press; 1980:130-134.
17. Merimee TJ, Quinn S, Russell B, Riley W. The growth hormone-insulin-like growth factor I axis: studies in man during growth. In: Raizada MK, LeRoith D, eds. Molecular Biology and Physiology of Insulin and Insulin-Like Growth Factors. New York, NY: Plenum Press; 1991:85-96.
18. Benjamin IJ, Jalil E, Tan LB, Cho K, Weber KT, Clark WA. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res. 1989;65:657-670.
19. Buja LM, Willerson JT. The role of coronary artery lesions in ischemic heart disease: insight from recent clinicopathologic, coronary arteriographic, and experimental studies. Hum Pathol. 1987;18:451-461.
20. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation. 1991;83: 1849-1865.
21. Lakatta EG. Length modulation of muscle performance: Frank-Starling law of the heart. In: Haber E, Jennings RB, Katz AM, Morgan HE, eds. The Heart and Cardiovascular System. New York, NY: Raven Press; 1986:319-843.
22. Nieminen MS, Elonen E, Pelkonen R, Frick MH. Acromegaly and the heart. Circulation. 1978;58:757.
23. Li Q, Li B, Wang X, Leri A, Jana KP, Liu Y, Kajstura J, Baserga R, Anversa P. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest. 1997;100: 1991-1999.
24. Resnicoff M, Burgaud J-L, Rotman HL, Abraham D, Baserga R. Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor 1 receptors. Cancer Res. 1995;55:3739-3741.
25. Duerr R, Huang S, Miraliakbar HR, Clark RG, Chien K, Ross J Jr. Insulin-like growth factor I enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest. 1995;95:619-627.
26. Fazio S, Sabatini D, Capaldo B, Vigorito C, Giordano A, Guida R, Pardo F, Biondi B, Saccà L. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med. 1996;334:809-814.
27. Buerke M, Murohara T, Skurk C, Nuss C, Tomaselli K, Lefer AM. Cardioprotective effect of insulin-like growth factor 1 in myocardial ischemia followed by reperfusion. Proc Natl Acatl Sci U S A. 1995;92: 8031-8035.
28. Decker RS, Cook MG, Behnke-Barclay M, Decker ML. Some growth factors stimulate cultured adult rabbit ventricular myocyte hypertrophy in the absence of mechanical loading. Circ Res. 1995;77:544-555.
29. Reiss K, Cheng W, Pierzchalski P, Kodali S, Li B, Wang S, Liu Y, Anversa P. Insulin-like growth factor-1 receptor and its ligand regulate the reentry of adult ventricular myocytes into the cell cycle. Exp Cell Res. 1997;235:198-209.
30. Cheng W, Reiss K, Li P, Chun MJ, Kajstura J, Olivetti G, Anversa P. Aging does not affect the activation of the myocyte insulin-like growth factor-1 autocrine system after infarction and ventricular failure in Fischer 344 rats. Circ Res. 1996;78:536-546.
31. Reiss K, Cheng W, Giordano A, De Luca A, Li B, Kajstura J, Anversa P. Myocardial infarction is coupled with the activation of cyclins and cyclin-dependent kinases in myocytes. Exp Cell Res. 1996;225:44-54.
32. Reiss K, Cheng W, Ferber A, Kajstura J, Li P, Li B, Olivetti G, Homcy CJ, Baserga R, Anversa P. Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice. Proc Natl Acad Sci U S A. 1996;93:8630-8635.
33. Agah R, Kirshenbaum LA, Abdellatif M, Truong LD, Chakraborty S, Michael LH, Schneider MD. Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo. J Clin Invest. 1997;100:2722-2728.